Alternatives to Acurex Biosciences
Acurex Biosciences is a Biotechnology tool: biotechnology company developing new medicines for Parkinson's disease and other neurological disorders. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotechnology companies to Acurex Biosciences
- Website
Moderna77BiotechnologyCambridge, United States$4.5BModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
- Website
Degron Therapeutics62BiotechnologySan Diego, USA$40.0MClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
- Website
CellCentric60BiotechnologyCambridge, United Kingdom$375.0MA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
- Website LŌLōkahi Therapeutics57BiotechnologyLa Jolla, USA$63.0M
A clinical-stage biopharmaceutical company developing novel therapies for neurological disorders.
- Website
Tortugas Neuroscience51BiotechnologyFramingham, USA$164.0MAdvancing clinical stage pipeline targeting new and major neurology and neuropsychiatric disorders.
- Website
Immitra Bio48BiotechnologyZürich, Switzerland$2.6MScalable, one-time curative in-vivo gene editing therapies.
- Website
mbiomics48BiotechnologyMunich, Germany$12.0MAdvancing scalable microbiome-based therapeutics for severe and chronic diseases.
- Website
Lysoway Therapeutics48BiotechnologyCambridge, USA$45.0MDeveloping small-molecule modulators of lysosomal ion channels for neurodegenerative diseases.
- Website
Draig Therapeutics48BiotechnologyNewton, United States$65.0MClinical-stage biopharmaceutical company developing transformative, best-in-class neuropsychiatric therapies.
- Website
ImmunityBio44BiotechnologyCulver City, USA$75.0MA commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.
- Website
Aelis Farma43BiotechnologyBordeaux, France$54.3MClinical-stage biopharmaceutical company developing treatments for brain and peripheral disorders involving the CB1 receptor.
- Website FOForlong Biotechnology42BiotechnologyShanghai, China$22.5M
Clinical-stage biotech company developing transformative cytokine therapies.
- Website
CRISPR Therapeutics64BiotechnologyZug, Switzerland$547.0MBiotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.
- Website
Epicrispr Biotechnologies62BiotechnologySouth San Francisco, United States$90.0MEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
- Website
LifeMine Therapeutics Inc.60BiotechnologyWatertown, United States$543.0MClinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.
- Website
Enterome60BiotechnologyParis, France$123.9MClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
- Website
Supernus Pharmaceuticals60BiotechnologyRockville, United States$17.5MBiopharmaceutical company developing and commercializing CNS disease treatments.
- Website
Adcendo60BiotechnologyCopenhagen, Denmark$272.0MDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
- Website
Infinimmune60BiotechnologyAlameda, United States$75.0MDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
- Website
Celerion59BiotechnologyLincoln, USA$45.0MA global leader in clinical pharmacology and bioanalytical sciences.
Showing the 20 closest matches. See the rest on the Acurex Biosciences profile.
Compare Acurex Biosciences head to head
Side by side on what each one does, what it costs, and what real users report.